Immobilization and Splinting
›Immobilization options
›Buddy taping to adjacent toe
›Rigid-sole shoe or post-op shoe
›Short walking boot when pain limits ambulation
›Position targets
›MTP
›Neutral to slight flexion for stability after reduction
›IP
›Functional alignment without hyperextension
›Post-immobilization reassessment
›Motor
›Sensation
›Cap refill
›Weight-bearing
›As tolerated in rigid-sole shoe when stable
›Heel weight-bearing if forefoot pain severe
›Indications
›Neurovascular compromise
›Threatened skin
›Severe deformity
›Fracture-dislocation with joint incongruity
›Contraindications or caution triggers
›Open dislocation with gross contamination
›Antibiotics and tetanus first when feasible
›Early specialist involvement
›Suspected interposed plantar plate or sesamoids in first MTP
›Limit repeated forceful attempts
›Early consultation after 1 to 2 failures
›Analgesia and anesthesia
›Non-opioid analgesia
›Acetaminophen PO 15 mg/kg
›Ibuprofen PO 10 mg/kg
›Opioid option for severe pain
›Morphine IV 0.05 to 0.1 mg/kg
›Digital nerve block
›Local anesthetic choices
›Lidocaine 1% without epinephrine
›Maximum 4.5 mg/kg
›Typical volume 3 to 5 mL per toe divided around base
›Bupivacaine 0.25%
›Maximum 2.5 mg/kg
›Longer duration for post-reduction pain
›Technique essentials
›Aspirate before injection
›Slow circumferential infiltration at toe base
›Procedural sedation when needed
›Indications
›Severe anxiety or inability to tolerate manipulation
›Failed reduction with adequate block due to muscle guarding
›Monitoring and safety
›Continuous pulse oximetry
›Capnography if available
›Airway equipment at bedside
›Suction
›BVM
›OPA and NPA
›Medication examples
›Ketamine IV
›Initial 1 mg/kg
›Additional 0.5 mg/kg every 5 to 10 minutes if needed
›Propofol IV
›Initial 0.5 mg/kg
›Additional 0.25 mg/kg every 1 to 3 minutes to effect
›MTP reduction technique
›Dorsal dislocation
›Longitudinal traction
›Slight hyperextension to disengage
›Plantar-directed pressure on proximal phalanx base
›Flexion into anatomic position
›Plantar dislocation
›Longitudinal traction
›Dorsal-directed pressure on proximal phalanx base
›Extension into anatomic position
›First MTP special considerations
›If toe locked in dorsiflexion with widened sesamoid gap, suspect Jahss Type I
›If failed closed reduction, likely need operative reduction
›IP reduction technique
›Longitudinal traction
›Reverse direction of displacement with focused pressure at middle phalanx base
›Avoid repeated forceful attempts to reduce osteochondral injury risk
›Post-reduction requirements
›Immediate neurovascular re-check
›Post-reduction radiographs
›Stability check with gentle passive ROM
›Immobilization in stable position
›Failed reduction pathway
›If 2 failed attempts, stop further attempts and consult
›If worsening pain or swelling, reassess for fracture and compartment risk
›If persistent NV deficit, emergent escalation
Open fracture medications and timing
›Antibiotics
›Timing
›Initiate as soon as possible for open injury
›First-line for low-contamination open toe injuries
›Cefazolin IV 25 to 50 mg/kg
›Maximum 2 g per dose
›Typical interval every 8 hours per protocol
›Severe beta-lactam allergy option
›Clindamycin IV 10 mg/kg
›Maximum 900 mg per dose
›Gross contamination
›Add gram-negative coverage per local protocol
›Tetanus prophylaxis
›If unknown or incomplete immunization, give tetanus vaccine
›If dirty wound and immunization incomplete, add tetanus immune globulin per protocol
›Wound care principles
›Copious irrigation
›Sterile dressing
›Avoid primary closure when heavily contaminated without specialist plan